- Home
- CVAC vs FTHY Comparison
CVAC vs FTHY Comparison
Compare CVAC & FTHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- FTHY
- Stock Information
- Founded
- CVAC 2000
- FTHY 2020
- Country
- CVAC Germany
- FTHY United States
- Employees
- CVAC N/A
- FTHY N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- FTHY Investment Managers
- Sector
- CVAC Health Care
- FTHY Finance
- Exchange
- CVAC Nasdaq
- FTHY Nasdaq
- Market Cap
- CVAC 637.1M
- FTHY 535.0M
- IPO Year
- CVAC 2020
- FTHY N/A
- Fundamental
- Price
- CVAC $2.95
- FTHY $14.69
- Analyst Decision
- CVAC Hold
- FTHY
- Analyst Count
- CVAC 3
- FTHY 0
- Target Price
- CVAC $10.00
- FTHY N/A
- AVG Volume (30 Days)
- CVAC 523.1K
- FTHY 176.7K
- Earning Date
- CVAC 11-12-2024
- FTHY 01-01-0001
- Dividend Yield
- CVAC N/A
- FTHY 10.93%
- EPS Growth
- CVAC N/A
- FTHY N/A
- EPS
- CVAC N/A
- FTHY N/A
- Revenue
- CVAC $70,565,734.00
- FTHY N/A
- Revenue This Year
- CVAC $738.59
- FTHY N/A
- Revenue Next Year
- CVAC N/A
- FTHY N/A
- P/E Ratio
- CVAC N/A
- FTHY N/A
- Revenue Growth
- CVAC 75.11
- FTHY N/A
- 52 Week Low
- CVAC $2.22
- FTHY $12.66
- 52 Week High
- CVAC $5.28
- FTHY $14.74
- Technical
- Relative Strength Index (RSI)
- CVAC 49.55
- FTHY 48.77
- Support Level
- CVAC $3.17
- FTHY $14.65
- Resistance Level
- CVAC $3.56
- FTHY $14.76
- Average True Range (ATR)
- CVAC 0.18
- FTHY 0.13
- MACD
- CVAC 0.01
- FTHY -0.00
- Stochastic Oscillator
- CVAC 24.69
- FTHY 36.84
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About FTHY First Trust High Yield Opportunities 2027 Term Fund
FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND is a diversified, closed-end management investment company. The investment objective of the fund is to provide current income.